Shilpa Medicare informs about company updates

04 Oct 2016 Evaluate

Shilpa Medicare has informed that the Company has received an approval from the United States Food & Drug Administration (USPDA) for Azacitidine - Injection Anda of SEZ Formulations Facility situated at Jadcherla, near Hyderabad.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

544.00 13.65 (2.57%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.